The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Widespread and Functional RNA Circularization in Localized Prostate Cancer
Open accessAbstract
The cancer transcriptome is remarkably complex, including low-abundance transcripts, many not polyadenylated. To fully characterize the transcriptome of localized prostate cancer, we performed ultra-deep total RNA-seq on 144 tumors with rich clinical annotation. This revealed a linear transcriptomic subtype associated with the aggressive intraductal carcinoma sub-histology and a fusion profile that differentiates localized from metastatic disease. Analysis of back-splicing events showed widespread RNA circularization, with the average tumor expressing 7,232 circular RNAs (circRNAs). The degree of circRNA production was correlated to disease progression in multiple patient cohorts. Loss-of-function screening identified 11.3% of highly abundant circRNAs as essential for cell proliferation; for ∼90% of these, their parental linear transcripts were not essential. Individual circRNAs can have distinct functions, with circCSNK1G3 promoting cell growth by interacting with miR-181. These data advocate for adoption of ultra-deep RNA-seq without poly-A selection to interrogate both linear and circular transcriptomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
ggplot2: Elegant Graphics for Data Analysis
Ginestet, C. E. (2011) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/j.1467-985x.2010.00676_9.x · Cited by 14,511
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Research works printed but not linked: 1
- Delignette-Muller, 2015, fitdistrplus: An RPackage for Fitting Distributions, J. Stat. Softw., 64, 1
Cited by
Sorted by citations
The role of non-coding RNAs in oncology
Slack, F. J., & Chinnaiyan, A. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.017 · Cited by 1,619
The expanding regulatory mechanisms and cellular functions of circular RNAs
Chen, L. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0243-y · Cited by 1,726
The emerging roles of circRNAs in cancer and oncology
Kristensen, L. S., Jakobsen, T., Hager, H., & Kjems, J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00585-y · Cited by 1,273
Goodall, G. J., & Wickramasinghe, V. O. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00306-0 · Cited by 1,090
Translation and functional roles of circular RNAs in human cancer
Lei, M., Zheng, G., Ning, Q., Zheng, J., & Dong, D. (2020) · Molecular Cancer · doi:10.1186/s12943-020-1135-7 · Cited by 814
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 641
Targeting circular RNAs as a therapeutic approach: current strategies and challenges
He, A. T., Liu, J., Li, F., & Yang, B. B. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00569-5 · Cited by 567
“A high-throughput shRNA-based screening was performed to evaluate the importance of specific circRNAs in prostate cancer.(73) This analysis identified 171 circRNAs as essential for cell proliferation.”
BackgroundProteogenomic Characterization of Endometrial Carcinoma
Dou, Y., Kawaler, E. A., Cui Zhou, D., Gritsenko, M. A., Huang, C., Blumenberg, L., Karpova, A., Petyuk, V. A., Savage, S. R., Satpathy, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.026 · Cited by 485
“Circular RNAs (circRNAs) have recently drawn interest for their role in tumor biology (Chen et al., 2019; Dragomir and Calin, 2018; Hansen et al., 2013; Kristensen et al., 2018; Vo et al., 2019).”
BackgroundSelf-citationChen, S., Zhu, G., Yang, Y., Wang, F., Xiao, Y., Zhang, N., Bian, X., Zhu, Y., Yu, Y., Liu, F., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-020-00613-6 · Cited by 503
Self-citationLi, B., Zhu, L., Lu, C., Wang, C., Wang, H., Jin, H., Ma, X., Cheng, Z., Yu, C., Wang, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20527-z · Cited by 697
Xie, M., Yu, T., Jing, X., Ma, L., Fan, Y. J., Yang, F., Ma, P., Jiang, H., Wu, X., Shu, Y., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01208-3 · Cited by 433
“expressed in tissue, and thousands of them have differential expression between tumor and normal tissue [6, 7].”
BackgroundSelf-citationWu, W., Ji, P., & Zhao, F. (2020) · Genome biology · doi:10.1186/s13059-020-02018-y · Cited by 425
Screening for functional circular RNAs using the CRISPR–Cas13 system
Li, S., Li, X., Xue, W., Zhang, L., Yang, L.-Z., Cao, S.-M., Lei, Y.-N., Liu, C.-X., Guo, S.-K., Shan, L., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-01011-4 · Cited by 365
“Cell 58, 870-885 (2015).”
Self-citationXia, X., Li, X., Li, F., Wu, X., Zhang, M., Zhou, H., Huang, N., Yang, X., Xiao, F., Liu, D., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1056-5 · Cited by 359
“The most recent study also supported that circRNAs and linear mRNAs may have individual functions during prostate cancer carcinogenesis [40].”
BackgroundSelf-citationEpigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis
Hanniford, D., Ulloa-Morales, A. J., Karz, A., Berzoti-Coelho, M. G., Moubarak, R. S., Sánchez‐Sendra, B., Kloetgen, A., Dávalos, V., Imig, J., Wu, P., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.12.007 · Cited by 348
“In contrast to a recent study in prostate cancer (Chen et al., 2019), we observed that the vast majority of DE circRNAs correlate strongly with their linear counterpart (Pearson, r > 0.”
ResultBiogenesis and Functions of Circular RNAs Come into Focus
Xiao, M., Ai, Y., & Wilusz, J. E. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.12.004 · Cited by 316
Targeting epigenetic regulators to overcome drug resistance in cancers
Wang, N., Ma, T., & Yu, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01341-7 · Cited by 334
“Acting as oncogenic factors or tumor suppressors, circRNAs are able to directly bind to proteins and interact with miRNAs to regulate cancer initiation.(92,93) Likewise, long non-coding RNAs are able to bind to both proteins and DNA to exert either tumor-promoting or tumorsuppressive effect.”
BackgroundBiogenesis and Regulatory Roles of Circular RNAs
Yang, L. C., Wilusz, J. E., & Chen, L. (2022) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-120420-125117 · Cited by 308
Circular RNA vaccine in disease prevention and treatment
Niu, D., Wu, Y., & Lian, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01561-x · Cited by 281
“331,332 It is worth mentioning that the establishment of engineered circRNAs to mimic endogenous or exosomal noncoding circRNAs, which enables the manipulation of ceRNA interactions, may engender new research fi elds or disease therapeutic schedules.”
BackgroundNanozyme-catalysed CRISPR assay for preamplification-free detection of non-coding RNAs
Broto, M., Kaminski, M. M., Adrianus, C., Kim, N., Greensmith, R., Dissanayake-Perera, S., Schubert, A. J., Tan, X., Kim, H., Dighe, A. S., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01179-0 · Cited by 260
Pervasive translation of circular RNAs driven by short IRES-like elements
Fan, X., Yang, Y., Chen, C., & Wang, Z. (2022) · Nature Communications · doi:10.1038/s41467-022-31327-y · Cited by 241
Pan, B., Qin, J., Liu, X., He, B., Wang, X., Pan, Y., Sun, H., Xu, T., Xu, M., Chen, X., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01096 · Cited by 232
Self-citationJiang, X., Guo, S., Wang, S., Zhang, Y., Chen, H., Wang, Y., Liu, R., Niu, Y., & Xu, Y. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-2988 · Cited by 218
Self-citationExosomal circRNA: emerging insights into cancer progression and clinical application potential
Zhang, F., Jiang, J., Qian, H., Yan, Y., & Xu, W. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01452-2 · Cited by 221
“Exosomal circRNAs have been shown to typically function as miRNA sponges or stabilizers [19, 20] and protein sponges or decoys [21].”
BackgroundRNA polymerase II speed: a key player in controlling and adapting transcriptome composition
Muniz, L., Nicolas, E., & Trouche, D. (2021) · The EMBO Journal · doi:10.15252/embj.2020105740 · Cited by 198
“Most importantly, recent results point to a causative role of circular RNAs on cancer progression (Chen et al , 2019).”
Okholm, T. L. H., Sathe, S., Park, S. S., Kamstrup, A. B., Rasmussen, A. M., Shankar, A., Chua, Z. M., Fristrup, N., Nielsen, M. M., Vang, S., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00812-8 · Cited by 204
Yu, Y., Lv, D., Wang, C., Song, X., Xie, T., Wang, T., Li, Z., Guo, J.-D., Fu, D.-J., Li, K., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01480-x · Cited by 185
“Recently, more and more circRNAs have been noticed dysregulated in different kinds of malignancies, which participated in diversified physiological and pathological processes of tumors cells, including proliferation, cell cycle progression, and metastasis [9].”
BackgroundChen, Q., Liu, T., Bao, Y., Zhao, T., Wang, J., Wang, H., Wang, A., Gan, X., Wu, Z., & Wang, L. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.017 · Cited by 180
The potential of using blood circular RNA as liquid biopsy biomarker for human diseases
Wen, G., Zhou, T., & Gu, W. (2020) · Protein & Cell · doi:10.1007/s13238-020-00799-3 · Cited by 183
Comprehensive characterization of circular RNAs in ~ 1000 human cancer cell lines
Ruan, H., Xiang, Y., Ko, J., Li, S., Jing, Y., Zhu, X., Ye, Y., Zhang, Z., Mills, T., Feng, J. Q., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0663-5 · Cited by 169
“functional roles to promote cell proliferation [14–16] and could serve as biomarkers in cancer [17, 18].”
BackgroundLin, J., Wang, X., Zhai, S., Shi, M., Peng, C., Deng, X., Fu, D., Wang, J., & Shen, B. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01348-7 · Cited by 172
“The loop structure of circRNAs makes them difficult to degrade in vivo, and they are widely abundant and specifically expressed in tumors and serum exosomes [13, 14].”
BackgroundZhang, Y., Nguyen, T. M., Zhang, X.-O., Wang, L., Phan, T., Clohessy, J. G., & Pandolfi, P. P. (2021) · Genome biology · doi:10.1186/s13059-021-02263-9 · Cited by 166
“Recently, shRNA-based functional screen has been employed to understand circRNA essentiality [15].”
BackgroundSelf-citationShen, P., Yang, T., Chen, Q., Yuan, H., Wu, P., Cai, B., Meng, L., Huang, X., Liu, J., Zhang, Y., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01333-7 · Cited by 166
Self-citationLu, J., Zhang, P., Huang, X., Guo, X.-J., Gao, C., Zeng, H., Zheng, Y.-M., Wang, S., Cai, J., Sun, Q., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01207-x · Cited by 168
Zhu, Z., Rong, Z., Luo, Z., Yu, Z., Zhang, J., Qiu, Z., & Huang, C. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1054-7 · Cited by 159
isoCirc catalogs full-length circular RNA isoforms in human transcriptomes
Xin, R., Gao, Y. P., Gao, Y., Wang, R., Kadash-Edmondson, K. E., Liu, B., Wang, Y., Lin, L., & Xing, Y. (2021) · Nature Communications · doi:10.1038/s41467-020-20459-8 · Cited by 169
circCAMSAP1 Promotes Tumor Growth in Colorectal Cancer via the miR-328-5p/E2F1 Axis
Zhou, C., Liu, H.-S., Wang, F., Hu, T., Liang, Z.-X., Lan, N., He, X.-W., Zheng, X.-B., Wu, X., Xie, D., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.12.008 · Cited by 157
“Mechanistically, studies have shown that some circRNAs might serve as a microRNA (miRNA) sponge to inhibit miRNA functions.(19,20) Some circRNAs could bind to proteins and regulate gene functions.”
BackgroundSelf-citationLandscape of Noncoding RNA in Prostate Cancer
Hua, J. T., Chen, S., & He, H. H. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.08.004 · Cited by 152
Self-citationCellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
Testa, U., Castelli, G., & Pelosi, E. (2019) · Medicines · doi:10.3390/medicines6030082 · Cited by 168
“The total circRNA burden correlates to disease progression in various patient cohorts [427].”
BackgroundInfluentialWang, X., Li, J., Bian, X., Wu, C., Hua, J., Chang, S., Yu, T., Li, H., Li, Y., Hu, S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012881118 · Cited by 156
Self-citationCircular RNAs: The star molecules in cancer
Liu, J., Li, D., Luo, H., & Zhu, X. M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.10.006 · Cited by 148
Wang, Y., Wang, Y., Qin, Z., Cai, S., Yu, L., Hu, H., & Zeng, S. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1887139 · Cited by 140
“177 circRNAs are essential for cancer development, indicating a large number of circRNAs are related to the process of cancer or even cancer MDR [106].”
BackgroundCircRNAs: biogenesis, functions, and role in drug-resistant Tumours
Ma, S., Kong, S., Wang, F., & Ju, S. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01231-4 · Cited by 140
HNRNPL Circularizes ARHGAP35 to Produce an Oncogenic Protein
Li, Y., Chen, B., Zhao, J., Li, Q., Chen, S., Guo, T., Li, Y., Lai, H., Chen, Z., Meng, Z., et al. (2021) · Advanced Science · doi:10.1002/advs.202001701 · Cited by 136
Self-citationGeng, X., Jia, Y., Zhang, Y., Shi, L., Li, Q., Zang, A., & Wang, H. (2019) · Epigenomics · doi:10.2217/epi-2019-0295 · Cited by 123
Self-citationAn Eight-CircRNA Assessment Model for Predicting Biochemical Recurrence in Prostate Cancer
Wang, S., Su, W., Zhong, C., Yang, T., Chen, W., Chen, G., Liu, Z., Wu, K., Zhong, W., Li, B., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.599494 · Cited by 121
“In our work, the mRNAs and circRNAs obtained based on high-throughput sequencing and clinical data of 144 PCa patients are from GSE113124.”
MethodInfluentialNuclear export of circular RNA
Ngo, L. H., Bert, A. G., Dredge, B. K., Williams, T. D., Murphy, V. J., Li, W., Hamilton, W. B., Carey, K. T., Toubia, J., Pillman, K. A., et al. (2024) · Nature · doi:10.1038/s41586-024-07060-5 · Cited by 121
Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates
Barani, M., Sabir, F., Rahdar, A., Arshad, R., & Kyzas, G. Z. (2020) · Nanomaterials · doi:10.3390/nano10091696 · Cited by 113
“Prostate cancer can be localized and advanced depending upon its severity [3].”
BackgroundHuang, X., He, M., Huang, S., Lin, R., Zhan, M., Yang, D., Shen, H., Xu, S., Cheng, W., Yu, J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1098-8 · Cited by 104
CircRNAs and their regulatory roles in cancers
Tao, M., Zheng, M., Xu, Y., Ma, S., Zhang, W., & Ju, S. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00359-3 · Cited by 102
Understanding and targeting prostate cancer cell heterogeneity and plasticity
Tang, D. G. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.001 · Cited by 102
Du, W. W., Yang, W., Li, X., Fang, L., Wu, N., Li, F., Chen, Y., He, Q., Liu, E., Yang, Z., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.03.002 · Cited by 100
Circular RNAs in physiology and non-immunological diseases
Chen, L., Huang, C., & Shan, G. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.11.004 · Cited by 98
Circular RNA CDR1as acts as a sponge of miR-135b-5p to suppress ovarian cancer progression
Chen, H., Mao, M., Jiang, J., Zhu, D., & Li, P. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s207938 · Cited by 98
“Numerous studies have also demonstrated that circRNAs play an important regulatory role in the progression of various types of human tumors.(6,7) Therefore, the study of the role of circRNAs in cancer can provide new targets for the diagnosis and treatment of cancers and improve the overall survival of cancer patients.”
de Fraipont, F., Gazzéri, S., Cho, W. C. S., & Eymin, B. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00390 · Cited by 93
Xie, T., Fu, D.-J., Li, Z., Lv, D., Song, X., Yu, Y., Wang, C., Li, K., Zhai, B., Wu, J., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01630-9 · Cited by 94
“In addition, using publicly available sequencing data for circRNAs [21], we validated the prognostic relationship between circSMARCC1 and biochemical recurrence (BCR) in PCa patients.”
MethodZhang, X., Niu, W., Mu, M., Hu, S., & Niu, C. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01695-8 · Cited by 90
“RNA pull-down with 5′-biotinylated AS oligos was used a previously described method [50].”
MethodEmerging Roles of Exosomal Circular RNAs in Cancer
Seimiya, T., Otsuka, M., Iwata, T., Shibata, C., Tanaka, E., Suzuki, T., & Koike, K. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.568366 · Cited by 92
Best practices to ensure robust investigation of circular RNAs: pitfalls and tips
Dodbele, S., Mutlu, N., & Wilusz, J. E. (2021) · EMBO Reports · doi:10.15252/embr.202052072 · Cited by 85
“There are currently conflicting data as to whether circular RNAs made in vitro trigger innate immune responses when added to cells (Chen et al , 2017; Wesselhoeft et al , 2018; Wesselhoeft et al , 2019; Chen et al , 2019b).”
Circular RNAs as promising biomarkers in cancer: detection, function, and beyond
Li, S., & Han, L. (2019) · Genome Medicine · doi:10.1186/s13073-019-0629-7 · Cited by 79
Guidance of circular RNAs to proteins’ behavior as binding partners
Luo, J., Liu, H., Luan, S., & Li, Z. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03216-z · Cited by 77
Mazrooei, P., Kron, K. J., Zhu, Y., Zhou, S., Grillo, G., Mehdi, T., Ahmed, M., Severson, T., Guilhamon, P., Armstrong, N. S., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.005 · Cited by 73
Self-citationZhao, J., Jiang, Y., Zhang, H., Zhou, J., Chen, L., Li, H. R., Xu, J., Zhang, G., & Jing, Z. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01931-9 · Cited by 75
Xu, Z., Chen, S., Liu, R., Chen, H., Xu, B., Xu, W., & Chen, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01607-8 · Cited by 75
Self-citationCui, Y., Wu, X., Jin, J., Man, W., Li, J., Li, X., Li, Y., He, Y., Liu, M., Zhong, R., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01888-7 · Cited by 76
“The landscape and action of circRNAs have been widely reported in various types of cancer [10], suggesting that circRNAs may be potential biomarkers or therapeutic targets [5, 11].”
BackgroundSelf-citationThe Circular RNA circHUWE1 Sponges the miR-29b-AKT3 Axis to Regulate Myoblast Development
Yue, B., Wang, J., Ru, W., Wu, J., Cao, X., Yang, H., Huang, Y., Lan, X., Lei, C., Huang, B., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.039 · Cited by 71
“Among potential functions of circRNA, ceRNA effects, by which circRNA sponges miRNAs to alleviate degradation or translation repression of target mRNAs, have been increasingly described, especially in processes related to oncology.(22) Many studies showed that ceRNA crosstalk could be related to processes of myogenesi…”
BackgroundCircular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia
Conn, V. M., Gabryelska, M., Toubia, J., Kirk, K., Gantley, L., Powell, J. A., Cildir, G., Marri, S., Liu, R., Stringer, B. W., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.05.002 · Cited by 75
Ding, L., Wang, R., Zheng, Q., Shen, D., Wang, H., Lu, Z., Luo, W., Xie, H., Ren, L., Jiang, M., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02391-5 · Cited by 70
Dong, Y., Gao, Q., Chen, Y., Zhang, Z., Du, Y., Liu, Y., Zhang, G., Li, S., Wang, G., Chen, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38232-y · Cited by 71
“We performed overlap analyses among the two cohorts in this study, circAtlas 61 , and the MiOncoCirc 62,63 database.”
The influence of BRCA2 mutation on localized prostate cancer
Taylor, R. A., Fraser, M. E., Rebello, R. J., Boutros, P. C., Murphy, D. G., Bristow, R. G., & Risbridger, G. P. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0164-8 · Cited by 68
Self-citationA Multi-Omics Perspective of Quantitative Trait Loci in Precision Medicine
Ye, Y., Zhang, Z., Liu, Y., Diao, L., & Han, L. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.01.009 · Cited by 68
Ahmed, M., Soares, F., Xia, J., Yang, Y., Li, J., Guo, H., Su, P., Tian, Y., Lee, H. J., Wang, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21867-0 · Cited by 61
Self-citationSensitive, reliable and robust circRNA detection from RNA-seq with CirComPara2
Gaffo, E., Buratin, A., Molin, A. D., & Bortoluzzi, S. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab418 · Cited by 62
“GSE113120 (24 samples) 22Rv1, 42D, PC3, V16, LNCaP [48]”
Li, S., Li, J., Zhang, H., Zhang, Y., Wang, X., Yang, H., Zhou, Z., Hao, X., Ying, G., & Ba, Y. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.04.099 · Cited by 61
Self-citationHe, Y., Tao, W., He, T., Wang, B.-Y., Tang, X., Zhang, L., Zhenquan, W., Deng, W., Zhang, L.-X., Shao, C., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01388-6 · Cited by 60
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors
Chen, S., Petricca, J., Ye, W., Guan, J., Zeng, Y., Cheng, N., Gong, L., Shen, S. Y., Hua, J. T., Crumbaker, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34012-2 · Cited by 66
Self-citationXin, S., Liu, X., Li, Z., Sun, X., Wang, R., Zhang, Z., Feng, X., Jin, L., Li, W., Tang, C., et al. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00407-0 · Cited by 62
“PCa is a malignant tumor with significant heterogeneity, including inter-tumor, intratumor, and clinical heterogeneity, which is manifested by spatial and clonal genomic diversity [9].”
Backgroundhsa_circ_0007841: A Novel Potential Biomarker and Drug Resistance for Multiple Myeloma
Gao, M., Li, C., Xiao, H., Dong, H., Jiang, S., Fu, Y., & Gong, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01261 · Cited by 59
“They reported that circCSNK1G3 competitively bind to miR-181b/d and exhibit fundamental function on four prostate cancer cells (22).”
BackgroundMa, J., Du, W. W., Zeng, K., Wu, N., Fang, L., Lyu, J., Yee, A., & Yang, B. B. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.08.002 · Cited by 59
Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy
Dong, X., & Chen, R. (2019) · Oncogene · doi:10.1038/s41388-019-1138-2 · Cited by 57
“Two recent studies reported widespread expression of circRNAs in prostate tumor tissue samples [110, 111], advocating efforts to search for PCa-specific circRNAs detectable in patient plasma or urine.”
BackgroundRNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets
Pan, Y., Kadash-Edmondson, K. E., Wang, R., Phillips, J., Liu, S., Ribas, A., Aplenc, R., Witte, O. N., & Xing, Y. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.01.006 · Cited by 59
“CircRNAs perform biological functions in normal cells but can be dysregulated in cancer cells, resulting in distinct circRNA expression profiles in tumor tissues [36, 37].”
BackgroundSelf-citationHNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness
Ho, J., Tullio, F. D., Schwarz, M. C., Low, D. H. P., Incarnato, D., Gay, F. P. H., Tabaglio, T., Zhang, J., Wollmann, H., Chen, L., et al. (2021) · eLife · doi:10.7554/elife.59654 · Cited by 60
“Data for circRNA in PCa patients was obtained from Chen et al., 2019 , NCBI GEO repository accession number: GSE113120.”
InfluentialSelf-citationCircRNA–miRNA networks in regulating bone disease
Huang, W., Wu, Y., Qiao, M., Xie, Z., Cen, X. B., Huang, X., & Zhao, Z. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30625 · Cited by 56
“Nowadays, we find circRNAs play vital roles in many physiological or pathological processes, such as regulation of the immune system, proliferation of cancer cells, and neuronal functions, and so on (S. Chen et al., 2019; Gokool et al., 2020; Z. Liu et al., 2019).”
BackgroundThe landscape of RNA polymerase II–associated chromatin interactions in prostate cancer
Ramanand, S. G., Chen, Y., Yuan, J., Daescu, K., Lambros, M. B. K., Houlahan, K. E., Carreira, S., Yuan, W., Baek, G., Sharp, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134260 · Cited by 54
Self-citationChen, W., Cen, S., Zhou, X., Yang, T., Wu, K., Zou, L., Luo, J., Li, C., Lv, D., & Mao, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.624764 · Cited by 59
Liu, X., Liu, X., Cai, M., Luo, A., He, Y., Liu, S., Zhang, X., Yang, X., Xu, L., & Jiang, H. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01395-7 · Cited by 56
“RNA pulldown assay A pulldown assay was performed as previously reported [27].”
MethodSelf-citationLi, D., Yang, Y. X., Li, Z.-Q., Li, L.-C., & Zhu, X. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000465 · Cited by 55
The role of noncoding RNAs in epithelial cancer
Agostini, M., Ganini, C., Candi, E., & Melino, G. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0247-6 · Cited by 56
Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis
Shi, J., Liu, C., Chen, C., Guo, K., Tang, Z., Luo, Y., Chen, L., Su, Y., & Xu, K. (2020) · Aging · doi:10.18632/aging.103432 · Cited by 55
“A recent study has revealed widespread expression and significant involvement of circRNAs in PCa [11].”
BackgroundLi, Y., Wang, Z., Gao, P., Cao, D., Dong, R., Zhu, M., Fei, Y., Zuo, X., & Cai, J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05498-9 · Cited by 55
“With advances in high-throughput sequencing technology, many novel circRNAs have been identified in various cancers [38].”
BackgroundPan-cancer pervasive upregulation of 3′ UTR splicing drives tumourigenesis
Chan, J. J., Zhang, B., Chew, X. H., Salhi, A., Kwok, Z. H., Lim, C. Y., Desi, N., Subramaniam, N., Siemens, A., Kinanti, T., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00913-z · Cited by 56
Circular RNAs in cardiovascular diseases
Mei, X., & Chen, S. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107991 · Cited by 55
Self-citationPotential miRNA Use as a Biomarker: From Breast Cancer Diagnosis to Metastasis
Jordan‐Alejandre, E., Campos-Parra, A. D., Castro-López, D. L., & Silva-Cázares, M. B. (2023) · Cells · doi:10.3390/cells12040525 · Cited by 54
Zheng, Z., Chen, Z., Zhong, Q., Zhu, D., Xie, Y., Shangguan, W., & Xie, W. (2021) · Cancer Science · doi:10.1111/cas.14814 · Cited by 51
Li, S., Weng, J., Song, F., Li, L., Xiao, C. W., Yang, W., Zhu, Z., & Xu, J. (2019) · Cell Death and Disease · doi:10.1038/s41419-020-2616-8 · Cited by 51
The transcriptional landscape and biomarker potential of circular RNAs in prostate cancer
Hansen, E. B., Fredsøe, J., Okholm, T. L. H., Ulhøi, B. P., Klingenberg, S., Jensen, J. B., Kjems, J., Bouchelouche, K., Borre, M., Damgaard, C. K., et al. (2022) · Genome Medicine · doi:10.1186/s13073-021-01009-3 · Cited by 50
“Two previous studies have characterized the landscape of circRNA in cancer [10] and in PC in particular [11], demonstrating that circRNA expression is dysregulated in several malignancies, including in PC.”
BackgroundYao, B., Zhu, S., Wei, X., Chen, M., Feng, Y., Li, Z., Xu, X., Zhang, Y., Wang, Y., Zhou, J., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01598-6 · Cited by 48
“For example, circCSNK1G3 has been shown to promote the progression of PCa by interacting with miR-181 [52].”
BackgroundSelf-citationPotential circRNA-disease association prediction using DeepWalk and network consistency projection
Li, G., Luo, J., Wang, D., Liang, C., Xiao, Q., Ding, P., & Chen, H. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103624 · Cited by 48
Novel insights into the interaction between N6-methyladenosine modification and circular RNA
Xu, T., He, B., Sun, H., Xiong, M., Nie, J., Wang, S., & Pan, Y. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.01.007 · Cited by 48
A New Era of Prostate Cancer Precision Medicine
Malik, A., Srinivasan, S., & Batra, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01263 · Cited by 49
Metadata
- Authors
- Chen, S., Huang, V., Xu, X., Livingstone, J., Soares, F., Jeon, J., Zeng, Y., Hua, J. T., Petricca, J., Guo, H., Wang, M., Yousif, F., Zhang, Y., Donmez, N., Ahmed, M., Volik, S., Lapuk, A., Chua, M. L. K., Heisler, L. E., Foucal, A., Fox, N. S., Fraser, M., Bhandari, V., Shiah, Y.-J., Guan, J., Li, J., Orain, M., Picard, V., Hovington, H., Bergeron, A., Lacombe, L., Fradet, Y., Têtu, B., Liu, S., Feng, F., Wu, X., Shao, Y. W., Komor, M. A., Sahinalp, C., Collins, C., Hoogstrate, Y., de Jong, M., Fijneman, R. J. A., Fei, T., Jenster, G., van der Kwast, T., Bristow, R. G., Boutros, P. C., & He, H. H.
- Affiliations
- Ontario Institute for Cancer Research (CA)
- University Health Network (CA)
- Vancouver Prostate Centre (CA)
- Fudan University (CN)
- Centre de recherche du CHU de Québec-Université Laval (CA)
- Sunnybrook Health Science Centre (CA)
- University of California, San Francisco (US)
- Nanjing Medical University (CN)
- The Netherlands Cancer Institute (NL)
- University of British Columbia (CA)
- Erasmus MC (NL)
- Northeastern University (CN)
- Corresponding author
- Boutros, Paul C.
- He, Housheng Hansen
- ORCID
- Chen, Sujun
- Huang, Vincent
- Xu, Xin
- Livingstone, Julie
- Soares, Fraser
- Jeon, Jouhyun
- Zeng, Yong
- Hua, Junjie Tony
- Guo, Haiyang
- Zhang, Yuzhe
- Ahmed, Musaddeque
- Lapuk, Anna
- Chua, Melvin L.K.
- Heisler, Lawrence E.
- Foucal, Adrien
- Fox, Natalie S.
- Fraser, Michael
- Bhandari, Vinayak
- Shiah, Yu-Jia
- Guan, Jiansheng
- Li, Jixi
- Orain, Michèle
- Picard, Valérie
- Hovington, Hélène
- Bergeron, Alain
- Lacombe, Louis
- Fradet, Yves
- Têtu, Bernard
- Liu, Stanley
- Feng, Felix
- Wu, Xue
- Shao, Yang W.
- Komor, Malgorzata A.
- Collins, Colin
- Hoogstrate, Youri
- Fijneman, Remond J.A.
- Fei, Teng
- Jenster, Guido
- Bristow, Robert G.
- Boutros, Paul C.
- He, Housheng Hansen
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 176
- Issue
- 4
- Pages
- 831-843.e22
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2913336364
- Cited by
- 544
- References
- 91
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 107 · 2023: 44 · 2022: 105 · 2021: 110 · 2020: 83 · 2019: 55
- FWCI
- 31.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Funders
- Princess Margaret Cancer Foundation (886012001223)
- Canada Foundation for Innovation and Ontario Research Fund (CFI32372)
- NSERC (498706)
- Canadian Cancer Society (705649, 703800)
- Prostate Cancer Canada (RS2014-01, RS2016-1022)
- CIHR (146586, 142246, 152863, 152864, 159567)
- Ontario Institute for Cancer Research
- TFRI
- OMIR
- Shanghai Committee of Science and Technology (18430711400)
- University of Toronto
- STARS21
- CTMM (03O-402)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Circular RNAs in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- circular RNA, RNA circularization, localized prostate cancer, back-splicing, intraductal carcinoma, metastatic prostate cancer, miR-181, cell proliferation, transcriptomic subtypes
- MeSH terms
- Genetic Profile, RNA, Circular, Humans, Male, Prostate, Prostatic Neoplasms, RNA, RNA Splicing, Sequence Analysis, RNA, Gene Expression Profiling, RNA, Untranslated, MicroRNAs, HEK293 Cells, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review